[{"address1": "2701 Kent Avenue", "city": "West Lafayette", "state": "IN", "zip": "47906", "country": "United States", "phone": "765 463 4527", "website": "https://www.inotivco.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services, including computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes general and genetic toxicology, regulated bioanalysis, carcinogenicity studies, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services, as well as model and research services. The company operates in the United States, the Netherlands, and internationally. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.", "fullTimeEmployees": 1955, "companyOfficers": [{"maxAge": 1, "name": "Ms. Beth A. Taylor CPA", "age": 58, "title": "Senior VP of Finance & CFO", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 461158, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brennan  Freeman", "age": 36, "title": "VP of Finance, Principal Accounting Officer & Corporate Controller", "yearBorn": 1987, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea  Castetter", "title": "Senior VP, General Counsel & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adrian  Hardy Ph.D.", "age": 52, "title": "Executive VP of Global Marketing & Corporate Development", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 2741606, "exercisedValue": 0, "unexercisedValue": 2461998}, {"maxAge": 1, "name": "Mr. Jeffrey Arthur Krupp", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Gregory Beattie DSA", "age": 56, "title": "Chief Operating Officer of DSA", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Garrett M.S.", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Glenn  Washer B.Sc., DABT", "age": 56, "title": "Group President of Safety Assessment", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lizanne  Muller", "title": "Group President of RMS", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 10, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.62, "open": 9.65, "dayLow": 9.42, "dayHigh": 10.03, "regularMarketPreviousClose": 9.62, "regularMarketOpen": 9.65, "regularMarketDayLow": 9.42, "regularMarketDayHigh": 10.03, "beta": 3.136, "forwardPE": -9.433963, "volume": 403077, "regularMarketVolume": 403077, "averageVolume": 361605, "averageVolume10days": 477160, "averageDailyVolume10Day": 477160, "bid": 9.97, "ask": 10.0, "bidSize": 200, "askSize": 100, "marketCap": 257907008, "fiftyTwoWeekLow": 1.61, "fiftyTwoWeekHigh": 10.03, "priceToSalesTrailing12Months": 0.44073713, "fiftyDayAverage": 5.7442, "twoHundredDayAverage": 4.2559, "currency": "USD", "enterpriseValue": 664426816, "profitMargins": -0.056739997, "floatShares": 23078274, "sharesOutstanding": 25790700, "sharesShort": 944029, "sharesShortPriorMonth": 1039852, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0366, "heldPercentInsiders": 0.10775, "heldPercentInstitutions": 0.19982, "shortRatio": 2.28, "shortPercentOfFloat": 0.038599998, "impliedSharesOutstanding": 25790700, "bookValue": 9.855, "priceToBook": 1.0147134, "lastFiscalYearEnd": 1696032000, "nextFiscalYearEnd": 1727654400, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -33205000, "trailingEps": -1.29, "forwardEps": -1.06, "enterpriseToRevenue": 1.135, "enterpriseToEbitda": 10.902, "52WeekChange": 1.118644, "SandP52WeekChange": 0.31995547, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "NOTV", "underlyingSymbol": "NOTV", "shortName": "Inotiv, Inc.", "longName": "Inotiv, Inc.", "firstTradeDateEpochUtc": 880468200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "18318147-29bb-3d77-9298-f38cbec7e217", "messageBoardId": "finmb_25587", "gmtOffSetMilliseconds": -14400000, "currentPrice": 10.0, "targetHighPrice": 25.0, "targetLowPrice": 10.0, "targetMeanPrice": 15.5, "targetMedianPrice": 11.5, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 22001000, "totalCashPerShare": 0.853, "ebitda": 60948000, "totalDebt": 428520992, "quickRatio": 1.043, "currentRatio": 1.742, "totalRevenue": 585171968, "debtToEquity": 168.602, "revenuePerShare": 22.786, "returnOnAssets": 0.004, "returnOnEquity": -0.12659, "freeCashflow": 10874250, "operatingCashflow": 28748000, "revenueGrowth": 0.104, "grossMargins": 0.29637, "ebitdaMargins": 0.10415, "operatingMargins": -0.06101, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-03-22"}]